The Department of Health and Human Services Indian Health Service is forecasting a recompete for a Pharmaceutical Prime Vendor (PPV) contract for pharmaceutical supplies, with an estimated solicitation release date of January 1, 2025, and an estimated award date of July 1, 2025. The contract will focus on pharmaceutical distribution under NAICS code 325412 for Pharmaceutical Preparation Manufacturing, targeting tribal healthcare facilities and related medical supply needs. The procurement aims to secure a comprehensive pharmaceutical supply and distribution solution for federal healthcare operations.

The forecasted contract opportunity has a potential ceiling value of $61,806,317,159.07, with a single-award approach targeting nationwide pharmaceutical distribution capabilities. Key points of contact include Sean Long, Contracting Officer, and Weston Thompson, NSSC Pharmacy Support Branch Supervisor, both from IHS, who can be reached at their respective government email addresses. The contract will require robust distribution infrastructure capable of delivering pharmaceuticals to approximately 750 customers, including federal facilities across the United States, territories, and specialized healthcare environments.

The existing award being recompeted is Contract Number 36W79720D0001, currently held by McKesson Corporation, which was originally awarded on August 9, 2020, with an ultimate completion date of August 9, 2028. The incumbent contract has a comprehensive scope covering controlled and non-controlled medications, specialty pharmaceuticals, and medical consumables, with delivery orders supporting various federal agencies including Indian Health Service, Bureau of Prisons, Department of Defense, and Peace Corps operations. The current contract's ceiling value is substantial at $61.8 billion, indicating the significant scale and importance of pharmaceutical distribution for federal healthcare systems.

McKesson Tribal PPV & OM

Forecast facts

About this forecast

Forecast text

Work this forecast